Coffee made from wormwood plant tested against prostate cancer return

NCT ID NCT05478239

Completed Disease control Sponsor: Zin W Myint Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 12, 2026 · Updated 3 times

Summary

This Phase 2 trial tests whether drinking three cups of ArtemiCoffee (made from the Artemisia annua plant) daily for 24 weeks can lower PSA levels in 20 men whose prostate cancer has returned after initial treatment. The goal is to see if at least half of the men experience a 50% drop in PSA, which could help manage the disease without more aggressive therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ArtemiCoffee (Artemisia annua coffee)
What this could lead to: If it works, this could offer a natural drink-based option to slow PSA rise in men with prostate cancer recurrence, potentially delaying the need for stronger treatments.
What could go wrong: This is a small early-phase trial with only 20 participants, so results may not apply to everyone. The coffee may not lower PSA enough, and side effects are not yet well understood.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

University of Kentucky

Lexington, Kentucky, 40536, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.